Netflix Plans All-Cash Bid for Warner Bros Discovery Studios Amid Intense Hollywood Takeover Battle 
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive 
BlueScope Steel Announces A$1 Special Dividend After Asset Sales 
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers 
Tesla, EEOC Move Toward Mediation in Racial Harassment Lawsuit 
Starlink Internet Remains Active in Iran Despite Nationwide Blackout 
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes 
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
Alphabet Stock Poised for Growth as Bank of America Sees Strong AI Momentum Into 2026 
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds 
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits 
Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease 
AFT Leaves X Over AI-Generated Images of Minors 
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny 
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures 
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows 
LOS ANGELES, March 31, 2017 -- Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against NantHealth (“NantHealth” or the “Company”) (Nasdaq:NH) concerning possible violations of federal securities laws. Investors who purchased shares (1) pursuant and/or traceable to the Company’s initial public offering (“IPO”) on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017 inclusive (the “Class Period”) should contact the firm prior to the May 8, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at [email protected].
No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
According to the Complaint, throughout the Class Period, NantHealth made materially false and/or misleading statements and/or failed to disclose: that its founder Patrick Soon-Shiong had donated funds through nonprofit organizations to the University of Utah for the purpose of funneling those funds back into NantHealth; that NantHealth and Soon-Shiong violated federal tax laws; that the Company improperly recorded orders received from the University of Utah as GPS Cancer test orders; and that the Company reported false and inflated GPS Cancer order figures for the third quarter of 2016.
Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.
This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethical rules.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected] http://lundinlawpc.com/
